Common Names
Geographic Range: China (Sichuan, Anhui, Hebei, Shandong, Jiangsu provinces), Japan, Korea
Known Contraindications
1
Compounds
1
Traditions
1
Treatments
2
Conditions
CC1=COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)CCYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | potent inhibitor |
| CYP2C9 | weak substrate |
| CYP2D6 | no significant interaction |
| CYP3A4 | moderate substrate |
| CYP2C19 | no significant interaction |
| clinical_note | Potent CYP1A2 inhibitor — caution with theophylline, caffeine, clozapine |